Total Payments
$26,357
2024 Payments
$91.96
Companies
23
Transactions
221
Medicare Patients
466
Medicare Billing
$242,622
Payment Breakdown by Category
Other$20,320 (77.1%)
Food & Beverage$4,954 (18.8%)
Travel$917.45 (3.5%)
Education$165.99 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,420 | 15 | 73.7% |
| Food and Beverage | $4,954 | 197 | 18.8% |
| Travel and Lodging | $917.45 | 5 | 3.5% |
| Honoraria | $900.00 | 2 | 3.4% |
| Education | $165.99 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $15,208 | 63 | $0 (2024) |
| Astellas Pharma US Inc | $5,314 | 30 | $0 (2022) |
| PFIZER INC. | $1,878 | 28 | $0 (2022) |
| Merck Sharp & Dohme LLC | $1,774 | 15 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $339.80 | 10 | $0 (2022) |
| Myovant Sciences Inc. | $312.17 | 11 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $274.52 | 24 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $147.73 | 3 | $0 (2022) |
| Axonics, Inc. | $143.51 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $121.77 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $91.96 | 3 | Janssen Biotech, Inc. ($52.26) |
| 2023 | $1,966 | 11 | Merck Sharp & Dohme LLC ($1,480) |
| 2022 | $19,041 | 126 | Janssen Biotech, Inc. ($14,660) |
| 2021 | $5,258 | 81 | Astellas Pharma US Inc ($2,939) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $52.26 | General |
| Category: Oncology | ||||||
| 03/13/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Oncology | ||||||
| 03/06/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: rezum_URO | ||||||
| 11/03/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $88.40 | General |
| Category: Urology | ||||||
| 09/29/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Urology | ||||||
| 08/11/2023 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,330.00 | General |
| Category: ONCOLOGY | ||||||
| 08/10/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Oncology | ||||||
| 06/30/2023 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2023 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: ONCOLOGY | ||||||
| 06/10/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $42.91 | General |
| Category: Oncology | ||||||
| 04/11/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $72.42 | General |
| Category: Oncology | ||||||
| 03/22/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $112.00 | General |
| Category: ONC | ||||||
| 02/01/2023 | Exelixis Inc. | — | Education | In-kind items and services | $99.00 | General |
| 01/24/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $41.56 | General |
| Category: Interventional Urology | ||||||
| 11/17/2022 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: Urology | ||||||
| 11/02/2022 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $3.64 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/01/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Oncology | ||||||
| 11/01/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Oncology | ||||||
| 11/01/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: Urology | ||||||
| 10/27/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $145.23 | General |
| Category: Oncology | ||||||
| 10/27/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Oncology | ||||||
| 10/27/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $13.67 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 10/27/2022 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/26/2022 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/25/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 142 | 350 | $63,898 | $25,027 |
| 2022 | 9 | 219 | 9,620 | $457,658 | $197,225 |
| 2021 | 2 | 26 | 29 | $3,879 | $1,079 |
| 2020 | 4 | 79 | 198 | $84,924 | $19,290 |
Total Patients
466
Total Services
10,197
Medicare Billing
$242,622
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 72 | 224 | $37,577 | $14,809 | 39.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 32 | 57 | $15,536 | $5,817 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 54 | $9,390 | $3,725 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 15 | $1,395 | $675.78 | 48.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 20 | 9,120 | $272,300 | $156,789 | 57.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 27 | 172 | $137,600 | $24,745 | 18.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 61 | $16,326 | $5,345 | 32.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 19 | 77 | $13,475 | $4,376 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 46 | $8,772 | $2,898 | 33.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 39 | $2,730 | $1,610 | 59.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 29 | 56 | $5,950 | $1,345 | 22.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 27 | 37 | $370.00 | $82.07 | 22.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 12 | 12 | $135.00 | $35.55 | 26.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 12 | $2,029 | $704.04 | 34.7% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2021 | 15 | 17 | $1,850 | $375.38 | 20.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2020 | 18 | 96 | $76,800 | $16,760 | 21.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 24 | $2,664 | $1,259 | 47.3% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2020 | 25 | 52 | $5,200 | $1,213 | 23.3% |
| 81003 | Automated urinalysis test | Office | 2020 | 18 | 26 | $260.00 | $58.25 | 22.4% |
About Lisa Devaney, CRNP
Lisa Devaney, CRNP is a Gerontology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2018. The National Provider Identifier (NPI) number assigned to this provider is 1861984155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lisa Devaney, CRNP has received a total of $26,357 in payments from pharmaceutical and medical device companies, with $91.96 received in 2024. These payments were reported across 221 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,420).
As a Medicare-enrolled provider, Devaney has provided services to 466 Medicare beneficiaries, totaling 10,197 services with total Medicare billing of $242,622. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Gerontology
- Location Philadelphia, PA
- Active Since 06/01/2018
- Last Updated 07/13/2023
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1861984155
Products in Payments
- ERLEADA (Drug) $15,230
- XTANDI (Drug) $3,903
- Xtandi (Drug) $2,303
- LYNPARZA (Biological) $1,500
- ORGOVYX (Drug) $1,212
- Nubeqa (Drug) $276.62
- PROVENGE (Drug) $274.52
- KEYTRUDA (Biological) $218.87
- Axonics (Device) $143.51
- Trodelvy (Drug) $112.00
- GEMTESA (Drug) $92.62
- LYNPARZA (Drug) $86.43
- UROLIFT (Device) $73.64
- Xofigo (Drug) $63.18
- Prolaris (Device) $60.40
- ELIGARD (Drug) $49.57
- UroLift System (Device) $44.41
- SpaceOAR VUE System - 10mL (Device) $38.79
- PYLARIFY (Drug) $33.08
- Myrbetriq (Drug) $32.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gerontology Doctors in Philadelphia
Mary Kelley, Crnp, CRNP
Gerontology — Payments: $8,172
Gerontology $8,172
Joyce Yablunsky, Rn, Crnp, Gnp-Bc, RN, CRNP, GNP-BC
Gerontology — Payments: $4,420
Gerontology $4,420
Miss. Lauren Robinson, Crnp, CRNP
Gerontology — Payments: $4,390
Gerontology $4,390
Denise Miller
Gerontology — Payments: $4,355
Gerontology $4,355
Jessy Palathinkal, Agnp, AGNP
Gerontology — Payments: $3,420
Gerontology $3,420
Olivia Carrasquillo, Np, NP
Gerontology — Payments: $3,127
Gerontology $3,127